Placeholder Banner

BIO Announces Plenary Sessions for 2017 World Congress on Industrial Biotechnology

March 22, 2017

Washington, D.C. (March 22, 2017) The Biotechnology Innovation Organization (BIO) today released the list of speakers for plenary programs at the 2017 World Congress on Industrial Biotechnology. The sessions will feature executives from the biofuels, household and personal care, and airline industries who will discuss technology breakthroughs, business partnerships and sustainability initiatives. The world’s largest industrial biotechnology event will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal, Québec, Canada. 

Brent Erickson, Executive Vice President, Industrial and Environmental at BIO, stated, “The Plenary Program for the 2017 World Congress will cover several novel topics that are emerging within the industry. Panelists will provide an overview of the current state of biobased food ingredients, flavorings, and personal care products and where market trends are headed in the future. Additionally, industry representatives and trade reporters will discuss how to meaningfully communicate about the biobased economy.”

Some highlighted Plenary Sessions include:

Biotech and the Future of Food Ingredients, Flavorings, and Personal Care 
Monday, July 24, 2017 
3:45 pm - 5:00 pm

Speakers:

  • Andreas Birmoser, Senior Vice President Strategy and Business Development, Stora Enso Biomaterials 
  • John Melo, President and Chief Executive Officer, Amyris 
  • Markus Pompejus, Vice President White Biotechnology Research North America, BASF Corporation
  • Jill Zullo, Vice President, Bioindustrials NA, Cargill

 

Second Generation Biofuels Poised for Big Wins
Tuesday, July 25, 2017
8:30 am - 10:00 am

Moderator: Jim Lane, Editor and Publisher, The Digest
Speakers: 

  • Marc Delcourt, Chief Executive Officer, Global Bioenergies
  • Jonas Markusson, Innovation and Product Development Manager, SEKAB (Invited)
  • Hermann Pengg, Head of Renewable Fuels & Lifecycle Analysis Department, Audi AG
  • Mario Pennisi, Chief Executive Officer, Life Sciences Queensland 
  • Mena Salib, Manager of Aircraft Noise and Emissions, Air Canada 

 

Effectively Communicating the Benefits of Industrial Biotechnology
Tuesday, July 25, 2017 
11:45 am – 1:30 pm 

Moderator: Rebecca Coons, Senior Editor, Chemical Week, IHS Chemical  
Speakers:
  • Herman Betten, Global Head of Public Relations, DSM
  • Melody Bomgardner, Senior Business Editor, Chemical & Engineering News
  • Doris de Guzman, Senior Consultant - Bio-Materials, Tecnon OrbiChem USA
  • Stephan Herrera, Vice President, Strategy and Public Affairs, Evolva
  • Sylvie Latieule, Director, Info Chimie Magazine

 

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference please visit http://www.bio.org/worldcongress.  For assistance, please contact worldcongress@bio.org.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

March 20-22, 2017
Barcelona, Spain
 
March 27-29, 2017
Newport Beach, CA
 
June 19-22, 2017
San Diego, CA
 
July 23 - 26, 2017
Montréal, Canada
Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…